Yaz Drug’s Side Effects Causing Lawsuits

Yasmin has been that causes aberrant blood clots, which have been seen to be a catalyzing agent for coronaries.
The clots are a consequence of 2 hormones contained in this contraception tablet : estogen and drospirenone. In a 2009 study revealed in the British Medical Book said that oral contraceptives mixing these 2 hormonal ingredients could pose a 6.3-fold increase in the danger of blood clots. This can most likely show millions of ladies to an increased possibility of deep vein thrombosis ( DVT ), pulmonary embolism and stroke.

If you have suffered from any medical illnesses after using these contraceptive you search the newest stories referring to your legal choices re any Yaz contraception side-effects court actions. Ocella and Yasmin suits are being pursued, on the behalf of girls, all though the US. How Yaz Blood Clots Trigger a coronary Myocardial transgression occurs when oxygen-rich blood is prevented from reaching the heart, and causes part of the muscle to die. The effect occurs inside minutes. The absence of oxygen and blood could cause permanent damage, which could spread over a period. There are two main coronary arteries, and many specific branches of secondary veins, that feed oxygenated blood to the heart. The veins spread across the outer layer of the myocardium ( i.e. Heart muscle ). Oftentimes a cardiac arrest is fired by a blood clot ( medically called a thrombus ) that lodges inside one of the arteries or supporting veins of the heart.
A thrombus will form at a site that's the results of your body's natural clotting mechanism.

 

Free Case Evaluation

Please Fill Out The Form Below To Have Your Case Evaluated For Free.
*denotes a required field
Invalid format
Invalid format Minimum number of characters not met. Invalid format Minimum number of characters not met.
Yasmin
Yaz
Ocella
Ortho Evra
Nuva Ring
DVT (deep vein thrombosis)
PE (pulmonary embolism)
Heart Attack
Stroke
Death
Blood Clot related Injury
Other
Yes
No
By submitting this form I agree to the following disclaimer.